GAN Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GAN in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" GAN stock.
View analyst ratings for GAN or view top-rated stocks.

Wall Street analysts have given GAN a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but GAN wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

GAN saw a drop in short interest during the month of February. As of February 12th, there was short interest totaling 1,730,000 shares, a drop of 18.8% from the January 28th total of 2,130,000 shares. Based on an average daily trading volume, of 1,480,000 shares, the days-to-cover ratio is currently 1.2 days. Currently, 7.5% of the shares of the stock are short sold.
View GAN's Short Interest.

GAN is scheduled to release its next quarterly earnings announcement on Thursday, March 25th 2021.
View our earnings forecast for GAN.

GAN will be holding an earnings conference call on Thursday, March 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

GAN Limited (NASDAQ:GAN) announced its earnings results on Sunday, November, 15th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by $0.16. The business earned $10.27 million during the quarter, compared to analyst estimates of $10.33 million. GAN had a positive trailing twelve-month return on equity of 0.61% and a negative net margin of 24.35%.
View GAN's earnings history.

4 brokerages have issued 1-year price objectives for GAN's shares. Their forecasts range from $24.00 to $35.00. On average, they expect GAN's share price to reach $29.25 in the next year. This suggests a possible upside of 4.0% from the stock's current price.
View analysts' price targets for GAN or view top-rated stocks among Wall Street analysts.

5 employees have rated GAN CEO Dermot Smurfit on Glassdoor.com. Dermot Smurfit has an approval rating of 63% among GAN's employees. This puts Dermot Smurfit in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to GAN include Cardlytics (CDLX), Yalla Group (YALA), Pluralsight (PS), SVMK (SVMK), Health Catalyst (HCAT), Internet Initiative Japan (IIJIY), Eventbrite (EB), Model N (MODN), EverQuote (EVER), Qutoutiao (QTT), HealthStream (HSTM), Aurora Mobile (JG), Sify Technologies (SIFY), TrueCar (TRUE) and Lizhi (LIZI).
View all of GAN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other GAN investors own include Altice USA (ATUS), Intel (INTC), Altria Group (MO), PG&E (PCG), AAR (AIR), Aptiv (APTV), Alteryx (AYX), Cogent Communications (CCOI), FTI Consulting (FCN) and Hill-Rom (HRC).

(GAN) raised $48 million in an IPO on Tuesday, May 5th 2020. The company issued 6,400,000 shares at $6.50-$8.50 per share. B. Riley FBR served as the underwriter for the IPO and Macquarie Capital was co-manager.

GAN trades on the NASDAQ under the ticker symbol "GAN."

GAN's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (3.39%), Primecap Management Co. CA (2.51%), Hood River Capital Management LLC (2.30%), Samjo Capital LLC (1.77%), Cowen Prime Services LLC (1.72%) and WCM Investment Management LLC (1.45%).
View institutional ownership trends for GAN.

GAN stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, New York State Common Retirement Fund, Essex Investment Management Co. LLC, and DAVENPORT & Co LLC.
View insider buying and selling activity for GAN or view top insider-selling stocks.

GAN stock was acquired by a variety of institutional investors in the last quarter, including Hood River Capital Management LLC, BlackRock Inc., Samjo Capital LLC, Primecap Management Co. CA, Cowen Prime Services LLC, Kennedy Capital Management Inc., WCM Investment Management LLC, and AWM Investment Company Inc..
View insider buying and selling activity for GAN or or view top insider-buying stocks.

Shares of GAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GAN stock can currently be purchased for approximately $28.12.

GAN has a market capitalization of $1.03 billion and generates $29.97 million in revenue each year.

GAN employs 215 workers across the globe.

The official website for GAN is www.gan.com.

GAN is headquartered at Axe & Bottle Court 70 Newcomen Street, London X0, SE1 1YT.

GAN's mailing address is Axe & Bottle Court 70 Newcomen Street, London X0, SE1 1YT. The company can be reached via phone at 44 20 7292 6262.